65 related articles for article (PubMed ID: 20498639)
1. CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1.
Leone V; Mansueto G; Pierantoni GM; Tornincasa M; Merolla F; Cerrato A; Santoro M; Grieco M; Scaloni A; Celetti A; Fusco A
Oncogene; 2010 Jul; 29(30):4341-51. PubMed ID: 20498639
[TBL] [Abstract][Full Text] [Related]
2. Ccdc6 knock-in mice develop thyroid hyperplasia associated to an enhanced CREB1 activity.
Leone V; Langella C; Esposito F; Arra C; Palma G; Rea D; Paciello O; Merolla F; De Biase D; Papparella S; Celetti A; Fusco A
Oncotarget; 2015 Jun; 6(17):15628-38. PubMed ID: 25970781
[TBL] [Abstract][Full Text] [Related]
3. Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity.
Luise C; Merolla F; Leone V; Paladino S; Sarnataro D; Fusco A; Celetti A
PLoS One; 2012; 7(11):e49298. PubMed ID: 23145146
[TBL] [Abstract][Full Text] [Related]
4. XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.
Lodyga M; De Falco V; Bai XH; Kapus A; Melillo RM; Santoro M; Liu M
Oncogene; 2009 Feb; 28(7):937-49. PubMed ID: 19060924
[TBL] [Abstract][Full Text] [Related]
5. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.
Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM
Oncogene; 1999 Jun; 18(24):3659-65. PubMed ID: 10380889
[TBL] [Abstract][Full Text] [Related]
6. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).
Nakazawa T; Kondo T; Kobayashi Y; Takamura N; Murata S; Kameyama K; Muramatsu A; Ito K; Kobayashi M; Katoh R
Cancer; 2005 Sep; 104(5):943-51. PubMed ID: 16015630
[TBL] [Abstract][Full Text] [Related]
7. Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells.
Ameziane-El-Hassani R; Boufraqech M; Lagente-Chevallier O; Weyemi U; Talbot M; Métivier D; Courtin F; Bidart JM; El Mzibri M; Schlumberger M; Dupuy C
Cancer Res; 2010 May; 70(10):4123-32. PubMed ID: 20424115
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle regulatory effects of retinoic Acid and forskolin are mediated by the cyclin C gene.
Makkonen KM; Malinen M; Ropponen A; Väisänen S; Carlberg C
J Mol Biol; 2009 Oct; 393(2):261-71. PubMed ID: 19683536
[TBL] [Abstract][Full Text] [Related]
9. Silencing of CCDC6 reduces the expression of 14-3-3σ in colorectal carcinoma cells.
Thanasopoulou A; Xanthopoulou AG; Anagnostopoulos AK; Konstantakou EG; Margaritis LH; Papassideri IS; Stravopodis DJ; Tsangaris GT; Anastasiadou E
Anticancer Res; 2012 Mar; 32(3):907-13. PubMed ID: 22399611
[TBL] [Abstract][Full Text] [Related]
10. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.
Corvi R; Berger N; Balczon R; Romeo G
Oncogene; 2000 Aug; 19(37):4236-42. PubMed ID: 10980597
[TBL] [Abstract][Full Text] [Related]
11. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
Sheils OM; O'Leary JJ; Sweeney EC
J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
[TBL] [Abstract][Full Text] [Related]
12. The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias.
Leone V; Ferraro A; Schepis F; Federico A; Sepe R; Arra C; Langella C; Palma G; De Lorenzo C; Troncone G; Masciullo V; Scambia G; Fusco A; Pallante P
Cancer Lett; 2015 Feb; 357(2):535-41. PubMed ID: 25497869
[TBL] [Abstract][Full Text] [Related]
13. Helioxanthin inhibits interleukin-1 beta-induced MIP-1 beta production by reduction of c-jun expression and binding of the c-jun/CREB1 complex to the AP-1/CRE site of the MIP-1 beta promoter in Huh7 cells.
Tseng PC; Hsu HC; Janmanchi D; Lin CH; Kuo YH; Chou CK; Yeh SF
Biochem Pharmacol; 2008 Oct; 76(9):1121-33. PubMed ID: 18789903
[TBL] [Abstract][Full Text] [Related]
14. CCDC6: the identity of a protein known to be partner in fusion.
Cerrato A; Merolla F; Morra F; Celetti A
Int J Cancer; 2018 Apr; 142(7):1300-1308. PubMed ID: 29044514
[TBL] [Abstract][Full Text] [Related]
15. Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage.
Merolla F; Luise C; Muller MT; Pacelli R; Fusco A; Celetti A
PLoS One; 2012; 7(5):e36177. PubMed ID: 22655027
[TBL] [Abstract][Full Text] [Related]
16. CCDC6, a gene product in fusion with different protoncogenes, as a potential chemotherapeutic target.
Laxmi A; Gupta P; Gupta J
Cancer Biomark; 2019; 24(4):383-393. PubMed ID: 30909182
[TBL] [Abstract][Full Text] [Related]
17. miR-130b-3p Upregulation Contributes to the Development of Thyroid Adenomas Targeting CCDC6 Gene.
Leone V; Langella C; Esposito F; De Martino M; Decaussin-Petrucci M; Chiappetta G; Bianco A; Fusco A
Eur Thyroid J; 2015 Dec; 4(4):213-21. PubMed ID: 26835423
[TBL] [Abstract][Full Text] [Related]
18. Effects of the G(-656)A variant on CREB1 promoter activity in a glial cell line: interactions with gonadal steroids and stress.
Zubenko GS; Hughes HB
Am J Med Genet B Neuropsychiatr Genet; 2008 Jul; 147B(5):579-85. PubMed ID: 18213625
[TBL] [Abstract][Full Text] [Related]
19. Direct observation of dimerization between different CREB1 isoforms in a living cell.
Sadamoto H; Saito K; Muto H; Kinjo M; Ito E
PLoS One; 2011; 6(6):e20285. PubMed ID: 21673803
[TBL] [Abstract][Full Text] [Related]
20. A Case of
Mejia Saldarriaga M; Steinberg A; Severson EA; Binder A
Front Oncol; 2019; 9():1303. PubMed ID: 31850206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
